ROSELLA – GOG-3073 – ENGOT-OV72/MITO: A phase 3 study of relacorilant + nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer (1241)

Alexander Olawaiye; Toon Van Gorp; Bradley Monk; Zoltan Novak; David O'Malley; Ana Oaknin; Thomas Herzog; Laurence Gladieff; Edwin Alvarez; Jacob Korach; John Chan; Shibani Nicum; Erin Bishop; Anita Chudecka-Glaz; Allan Covens; Carolyn Muller; Gina Westhoff; David Fishman; Lyndah Dreiling; Hristina Pashova; Iulia Cristina Tudor; Domenica Lorusso

doi:10.1016/j.ygyno.2023.06.150

Back

ROSELLA – GOG-3073 – ENGOT-OV72/MITO: A phase 3 study of relacorilant + nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer (1241)

Journal article

Peer reviewed

ROSELLA – GOG-3073 – ENGOT-OV72/MITO: A phase 3 study of relacorilant + nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer (1241)

Alexander Olawaiye, Toon Van Gorp, Bradley Monk, Zoltan Novak, David O'Malley, Ana Oaknin, Thomas Herzog, Laurence Gladieff, Edwin Alvarez, Jacob Korach, …

Gynecologic oncology, Vol.176, pp.S153-S154

09/2023

DOI: https://doi.org/10.1016/j.ygyno.2023.06.150

Metrics

3 Record Views

Details

Title: ROSELLA – GOG-3073 – ENGOT-OV72/MITO: A phase 3 study of relacorilant + nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer (1241)
Creators: Alexander Olawaiye - University of Pittsburgh
Toon Van Gorp - KU Leuven
Bradley Monk - University of Arizona
Zoltan Novak - National Institute of Oncology
David O'Malley
Ana Oaknin - Vall d'Hebron Hospital Universitari
Thomas Herzog - University of Cincinnati
Laurence Gladieff - Institut Claudius Regaud
Edwin Alvarez - University of California, San Francisco
Jacob Korach - Sheba Medical Center
John Chan - California Pacific Medical Center
Shibani Nicum - University College London
Erin Bishop - Medical College of Wisconsin
Anita Chudecka-Glaz
Allan Covens - Sunnybrook Health Science Centre
Carolyn Muller - University of New Mexico
Gina Westhoff - Legacy Health
David Fishman
Lyndah Dreiling - Corcept Therapeutics
Hristina Pashova - Corcept Therapeutics
Iulia Cristina Tudor - Corcept Therapeutics
Domenica Lorusso - Agostino Gemelli University Polyclinic
Publication Details: Gynecologic oncology, Vol.176, pp.S153-S154
Identifiers: 991006041370002656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article

ROSELLA – GOG-3073 – ENGOT-OV72/MITO: A phase 3 study of relacorilant + nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer (1241)

Related links

Metrics

Details

ROSELLA – GOG-3073 – ENGOT-OV72/MITO: A phase 3 study of relacorilant + nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer (1241)